Comstock Mining (LODE) Corporate Presentation from NobleCon18Research, News and Market Data on Comstock MiningNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


6/20/2025
Natural Resources
Release – Nicola Mining Commences Exploration Drilling at Its Flagship New Craigmont Copper Project
Nicola Mining Inc.  (TSX: NIM) (OTCQB: HUSIF) (FSE: HLIA) (the “Company” or “Nicola”) is pleased to announce commencement of the 2025 Exploration Diamond Drilling Program (the “2025 Program”) at its New Craigmont Copper Project...
5 min read
‌


6/20/2025
Natural Resources
Oil Prices Rise for Third Week as Markets Brace for Trump’s Decision on Iran
Oil markets wrapped up their third consecutive week of gains on Friday as investors watched closely for U.S. President Donald Trump’s next move regarding the Israel-Iran conflict. West Texas Intermediate...
3 min read
‌


6/20/2025
Health
Nutriband (NTRB) – Manufacturing Milestone Allows Development To Move Forward As Expected
Preparing For AVERSA Fentanyl Clinical Testing. Nutriband and its partner Kindeva announced that it has completed commercial manufacturing processes and scale-up for AVERSA Fentanyl, its abuse-deterrent fentanyl patch. This allows the...
2 min read
‌


6/20/2025
Health
MAIA Biotechnology (MAIA) – Roche Forms Supply Agreement For THIO Combination Studies
MAIA Makes Its Third Supply Agreement. MAIA announced that it has entered a supply agreement with Genentech/Roche to test THIO (ateganosine) in combination with Tecentriq (atezolizumab, Roche’s PD-L1 checkpoint inhibitor) for...
2 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.